Skip to main content
Erschienen in: BMC Pregnancy and Childbirth 1/2023

Open Access 01.12.2023 | Research

Uterus-preserving surgical management of placenta accreta spectrum disorder: a large retrospective study

verfasst von: Wenxia Pan, Juan Chen, Yinrui Zou, Kun Yang, Qingfeng Liu, Meiying Sun, Dan Li, Ping Zhang, Shixia Yue, Yuqiang Huang, Zhaoxi Wang

Erschienen in: BMC Pregnancy and Childbirth | Ausgabe 1/2023

Abstract

Background

The two-child policy implemented in China resulted in a surge of high-risk pregnancies among advanced maternal aged women and presented a window of opportunity to identify a large number of placenta accreta spectrum (PAS) cases, which often invoke severe blood loss and hysterectomy. We thus had an opportunity to evaluate the surgical outcomes of a unique conservative PAS management strategy for uterus preservation, and the impacts of magnetic resonance imaging (MRI) in PAS surgical planning.

Methods

Cross-sectional study, comparing the outcomes of a new uterine artery ligation combined with clover suturing technique (UAL + CST) with the existing conservative surgical approaches in a maternal public hospital with an annual birth of more than 20,000 neonates among all placenta previa cases suspecting of PAS between January 1, 2015 and December 31, 2018.

Results

From a total of 89,397 live births, we identified 210 PAS cases from 400 singleton pregnancies with placenta previa. Aside from 2 self-requested natural births (low-lying placenta), all PAS cases had safe cesarean deliveries without any total hysterectomy. Compared with the existing approaches, the evaluated UAL + CST had a significant reduction in intraoperative blood loss (β=-312 ml, P < .001), RBC transfusion (β=-1.08 unit, P = .001), but required more surgery time (β = 16.43 min, P = .01). MRI-measured placenta thickness, when above 50 mm, can increase blood loss (β = 315 ml, P = .01), RBC transfusion (β = 1.28 unit, P = .01), surgery time (β = 48.84 min, P < .001) and hospital stay (β = 2.58 day, P < .001). A majority of percreta patients resumed normal menstrual cycle within 12 months with normal menstrual fluid volume, without abnormal urination or defecation.

Conclusions

A conservative surgical management approach of UAL + CST for PAS is safe and effective with a low complication rate. MRI might be useful for planning PAS surgery.

Clinical trial registration number

: ChiCTR2000035202.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1186/​s12884-023-05923-9.
denotes co-first-author, these authors contributed equally to this work.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Background

Placenta accreta spectrum (PAS) is pathologic adherence and excessive penetration of part or all of the placenta into the myometrium, including accreta, increta, or percreta [13]. Placenta previa, prior cesarean delivery (CD), uterine surgery, multiparity, advanced maternal age, as well as in vitro fertilization are risk factors associated with the worldwide increase in PAS [47]. PAS can induce massive hemorrhage as the placenta cannot separate spontaneously at delivery, which often requires cesarean hysterectomy to control serious bleeding. The intraoperative blood loss is reported to range from 2,000 to 5,000 ml, and frequently blood transfusion is needed. In severe cases, PAS can cause maternal death, with mortality rate as high as 6–7% [8, 9].
The management of PAS include early prenatal screening and referral to tertiary centers with experienced multidisciplinary teams [1012]. Obstetrical ultrasound in the second or third trimester is the primary method for the screening and diagnosis of PAS, but it suffers from high inter-operator variability and low reproducibility, and it cannot obtain a panorama view of placenta [13]. With better visualization of pelvic organs and additional details of the utero-placental relationship, magnetic resonance imaging (MRI) has also been adopted as an antenatal diagnostic tool [14]. Currently, there are still controversies regarding the benefits of MRI, particularly given the increased cost of MRI.
According to International Federation of Gynecology and Obstetrics (FIGO) guidelines, the principal surgical strategy to prevent excessive bleeding related to PAS is to leave the placenta in situ and perform a primary peripartum hysterectomy at delivery [15]. A hysterectomy may be not preferred by patients wishing to preserve fertility and is detrimental to multiple aspects of pelvic floor, bowel and physical functions [1618]. Moreover, in some cultures, the removal of her uterus may reduce a woman’s societal status and therefore negatively impact her self-esteem [15].
After China raised a family’s limit on children to two at the end of 2015, there was an increase in second pregnancies, and the incidence of PAS and associated maternal deaths dramatically increased across the country [19]. As the only tertiary referral center for maternal and child healthcare in Linyi City, Shandong, China, a major metropolitan area with a population of 11 million people, the study center has accumulated a large number of PAS cases. This region believes in the traditional Chinese value that multiple children are fundamental to family happiness and harmony. Therefore, conservative approach of preserving uterus is commonly implemented in obstetric practice here. Gradually, an obstetric surgeon developed a technique, which combines uterine artery ligation with clover suture technique (UAL + CST) together. This technique prevents excessive bleeding and preserves uterus. Meantime, other surgery teams continued with existing compression sutures including B-lynch suture, modified B-lynch suture, CHO suture and row suture [2023].
The purpose of this study was to compare the UAL + CST approach and other existing approaches by measuring blood loss using direct measurement and gravimetric methods, blood transfusion, and other adverse effects to determine the feasibility of UAL + CST approach. The secondary purpose was to evaluate the impact of MRI in PAS management, as it was commonly implemented in obstetric practice in this center.

Methods

This retrospective study was conducted at Linyi Maternal and Child Healthcare Hospital, Shandong, China, one of the largest hospitals by annual live births in China. This study was approved by the Institutional Review Board of Linyi Maternal and Child Healthcare Hospital. Subjects were eligible for inclusion if they delivered a live birth between January 1, 2015 and December 31, 2018 in the study center.
In chart review, a physician team manually screened electronic medical records for a diagnosis of placenta previa. Then, PAS cases were identified by reviewing ultrasound reports, MRI reports, and surgical reports from previa cases. Twin pregnancies were excluded. PAS cases were classified into four groups including accreta (grade 1), increta (grade 2), and percreta (grade 3), according to FIGO clinical classification [1].
This center has a routine ultrasonographic screening program for placenta previa. An ultrasonography is performed monthly in accordance with the recommendations from FIGO [24]. If any ultrasound exam suggests placenta previa, the patient is transferred to the dedicated outpatient service. If PAS is suspected at approximately 30 weeks of gestation, obstetricians would prescribe an MRI examination using a modified protocol [25].
The elections of the UAL + CST surgery or other existing conventional approaches, including B-lynch suture, modified B-lynch suture, CHO suture, row suture and hysteroplasty, was not based on preoperative assessment but on the schedule of surgeons and could not be switched intraoperatively. In the UAL + CST approach, four surgical steps were performed thereafter. First, the bladder was pushed down to ligate invading blood vessels as the plane between the bladder and the uterus is relatively clear at that stage, and therefore easier to identify. Second, lift the upper edge of the abdominal incision with an abdominal wall hook, and a vertical or horizontal incision was made on the upper uterus. After delivering the fetus, while avoiding touching the placenta, the umbilical cord was cut and oxytocin is injected into the body of uterus. Third, at 1 centimeter inside the interface of uterine artery and lateral margin of uterus, the ascending branch of uterine artery was ligated together with some myometrium tissue, the ligation thread and the lateral margin of uterus forming a 30 degree angle, avoiding the ureter (Fig. 1a). Fourth, the placenta was extracted manually, and CST (Fig. 1b) was performed on the lower uterus. CST was proposed by the team specifically for PAS surgery. It was usually performed on the lower segment of the uterus, and also on the cervix when the placenta invasion reached the cervix, during which cervical CST proceeds uterine CST. Figure 1b shows the condition when CST was performed both on the cervix and the lower segment of the uterus, and Fig. 1c is a picture when CST was done. (For detailed description of CST, see supplement material 2). Partial hysterectomy (excision of partial uterine wall) was performed when it was deemed too difficult to separate the placenta manually. For detailed surgery process please refer to supplement material 1.
MRI was widely used for close examination of patients’ utero-placenta structure and surgical planning in this center. For objective evaluation of the impact of MRI, we measured the placenta thickness and used this parameter in data analysis.
We also prospectively followed the most severe 19 cases of percreta (grade 3), including their gynecological examinations, emergency care, menses recovery, and incidences of abdominal pain, abnormal urination and defecation. Written informed consents were obtained.
Epidata was used for data collection and SPSS 25.0 package was used for data analysis. Continuous values were presented as mean ± SD, or median (interquartile range). Categorical values were expressed as counts (percentage). For continuous variables, Kolmogorov–Smirnov analysis was applied to test distribution. If normally distributed, independent t test was performed; if skewed distributed, logarithmic conversions were performed and the distribution was tested again; if still skewed distributed, the Mann Whitney U test was performed. For categorical variables, we performed the Chi Square test or Fisher exact test. Multivariate linear regression analysis was also performed. P < .05 at both sides was considered to be statistically significant.

Results

During the four-year study period, there was a total of 89,397 live births at the study center, of which 400 singleton placenta previa cases were identified (Table 1). Specifically, 210 cases complicated with PAS, including 107 accreta cases (grade 1), 84 increta (grade 2) cases, and 19 percreta cases (including 11 grade 3a and 8 grade 3b).
Table 1
Demographic characteristics
 
Accreta
Increta
Percreta
Variable
UAL + CST
Existing Approach
P
UAL + CST
Existing Approach
P
UAL + CST
Existing Approach
P
(N = 44)
(N = 63)
(N = 60)
(N = 24)
(N = 15)
(N = 4)
Age, yrs a
32.0 (28.0-38.8)
31.0 (27.0–36.0)
0.23
32.0 (30.0–36.0)
32.0 (28.0-35.5)
0.71
30.0 (29.0–34.0)
33.0 (28.8–35.0)
0.64
Gestation age at delivery, wks a
37.4 (36.6–38.3)
37.1 (35.0-38.3)
0.47
36.9 (35.7–37.6)
37.1 (36.1–38.1)
0.33
36.7 (35.1–37.6)
37.5 (28.0-38.9)
0.47
Gravidity, n (%) b
  
0.32
  
0.78
  
1
≤ 4
33 (75)
53 (84)
 
46 (77)
18 (71)
 
10 (67)
3 (75)
 
> 4
11 (25)
10 (16)
 
14 (23)
7 (29)
 
5 (33)
1 (25)
 
Parity, n (%) b
  
0.23
  
0.28
  
0.3
≤ 1
41 (93)
53 (84)
 
46 (77)
15 (63)
 
6 (40)
3 (75)
 
> 1
3 (7)
10 (16)
 
14 (23)
9 (37)
 
9 (60)
1 (25)
 
Number of previous CD, n (%) c
  
0.049
  
0.52
  
0.68
0
26 (59)
50 (79)
 
20 (33)
6 (25)
 
1 (6))
0
 
1
16 (36)
12 (19)
 
31 (52)
12 (50)
 
7 (47)
3 (75)
 
2
2 (5)
1 (2)
 
9 (15)
6 (25)
 
7 (47)
1 (25)
 
APGAR scores < 7, n (%)
         
At 1 min c
2 (5)
5 (8)
0.7
4 (7)
2 (8)
1
1 (100)
0
1
At 5 min c
0
0
N/A
1 (2)
0
1
0
0
NA
Delivery weight, ga
3080 (2850–3443)
3028 (2663–3390)
0.3
2970 (2600–3330)
3050 (2650–3430)
0.33
2751 ± 478
3463 ± 270
0.03d
Placenta thickness, mm a
36.7 (33.1–41.8)
38.0 (31.0–43.0)
0.91
39.3 (33.0-50.8)
37.5 (32.8–44.8)
0.51
43.0 (31.6–48.8)
36.5 (32.3–56.8)
0.871
MRI, n (%) b
22 (50)
11 (18)
0.001
35 (58)
11 (46)
0.34
11 (73)
3 (75)
1
Surgery type, n (%) c
  
0.65
  
0.06
  
1
Elective surgery
23 (52)
27 (43)
 
31 (52)
12 (50)
 
10 (67)
3 (75)
 
Gestation age at delivery, wks a
37.4 (37.1–38.6)
37.7 (36.7–39.0)
0.653
37.1 (36.4–37.6)
37.3 (36.5–38.5)
0.457
36.7 ± 1.5
38.0 ± 1.1
0.169 d
Inpatient emergency surgery
9 (21)
16 (25)
 
6 (10)
7 (29)
 
0
0
 
Gestation age at delivery, wks a
36.9 (36.5–37.9)
36.2 (33.4–38.1)
0.607
35.7 ± 2.3
36.3 ± 1.8
0.598d
NA
NA
NA
Outpatient emergency surgery
12 (27)
20 (32)
 
23 (38)
5 (21)
 
5 (33)
1 (25)
 
Gestation age at delivery, wks a
36.7 (35.2–38.3)
36.1 (30.6–38.0)
0.402
36.1 (32.6–37.1)
36.9 (35.0–38.0)
0.455
34.9 ± 3.1
25.0
NA
Values are given as median (interquartile range), mean ± SD or number of subjects (percentage), unless indicated otherwise
Gravidity, parity and number of previous CD values are before the studied delivery values
CD: cesarean delivery; APGAR: activity, pulse, grimace, appearance and respiration; MRI: magnetic resonance imaging; SD: standard deviation
a Mann Whitney U test
b Chi-square test
c Fisher’s exact test
d Independent T test
Excluding 2 cases delivered vaginally (low-lying placenta, self-requested vaginal delivery), 208 PAS cases had CD with 106 elective surgery (50.5%) and 104 emergency surgery (49.5%) (Table 1). For accreta group, patients received UAL + CST generally had more previous CD than those having the existing approaches (P = .05). For percreta group, newborn birth weight in UAL + CST surgery group were significantly lower than those using the existing approaches (P = .03). Additionally, the surgeon using UAL + CST in accreta groups were more likely to employ MRI to plan surgery (P = .001, respectively). Other demographic characteristics of all groups were comparable.
There was no total cesarean hysterectomy performed on any subject, but 33 (15%) PAS cases had partial hysterectomies (excision of partial uterine wall) mostly associated with deep PAS penetration, including 25% of increta cases and 63% of percreta cases (Table 2). Though data did not show significant difference, the UAL + CST approach needed less partial hysterectomy (excision of partial uterine wall) than the existing approaches. Additionally, there were only 6 (1.5%) puerperal infections among all groups, and 4 (21%) bladder injuries in the percreta group. None of the adverse effects showed significant difference between the two surgical approaches in all groups. However, UAL + CST showed significant protective effect in terms of lower operative blood loss (P = .01) and need for transfusion (P = .05) in increta group than conventional approaches. Besides, the UAL + CST did require more surgery time as suggested in accreta (P = .001) and increta (P = .02) groups. In contrast, the UAL + CST only had an average of ~ 15 min increase of surgical time (P = .001) in the accreta cases. Considering the small number of percreta cases, the UAL + CST had a lower average intraoperative blood loss but only at a marginal significance.
Table 2
Surgery Outcomes
 
Accreta
Increta
Percreta
Outcome
UAL + CST
Existing Approach
P
UAL + CST
Existing Approach
P
UAL + CST
Existing Approach
P
(N = 44)
(N = 63)
(N = 60)
(N = 24)
(N = 15)
(N = 4)
Intraoperative blood loss (mL) a
300 (300–500)
400 (300–500)
0.17
500 (300–800)
800 (500–2000)
0.01
600 (500–1000)
2000 (850–3375)
0.052
Intraoperative blood loss > 1,500mLc
1 (1)
0
0.41
3 (5)
7 (29)
0.01
3 (20)
2 (50)
0.27
Intraoperative RBC transfusion (u) a
0.00 (0.00–0.00)
0.00 (0.00–0.00)
0.37
0.00 (0.00-3.88)
2.00 (0.00–4.00)
0.048
2.00 (0.00–4.00)
4.00 (4.00-12.63)
0.12
Massive RBC transfusion (≥ 6u) c
0
0
NA
1 (2)
4 (17)
0.02
3 (20)
1 (25)
1
Any RBC transfusion b
4 (9)
10 (16)
0.39
21 (35)
12 (50)
0.225
9 (60)
4 (100)
0.26
Surgery duration (min) a
64.0 (50.0-79.5)
50.0 (45.0–60.0)
0.001
110.0 (75.5–145.0)
75.5 (53.5-122.5)
0.02
187.3 ± 79.2
180.7 ± 69.7
0.88d
Hysterectomy
0
0
NA
0
0
NA
0
0
NA
Postoperative hospital stays (day) a
4.0 (3.0–5.0)
4.0 (3.0–4.0)
0.48
5.0 (4.0–7.0)
4.5 (4.0–6.0)
0.15
7.0 (6.0–15.0)
11.0 (6.3–15.8)
0.59
Puerperal infection c
0
1 (2)
1
2 (3)
0
1
0
1 (25)
0.21
Bladder Injury
0
0
NA
0
0
NA
3 (20)
1 (25)
1
Ureteral Injury
0
0
NA
0
0
NA
0
0
NA
Intestinal Injury
0
0
NA
0
0
NA
0
0
NA
Placenta remains
0
0
NA
0
0
NA
0
0
NA
Reoperation c
0
0
NA
1 (2)
0
1
0
0
NA
Partial hysterectomy c
0
0
NA
14 (23)
7 (29)
0.78
8 (53)
4 (100)
0.25
Partial bladder resection c
0
0
NA
0
0
NA
2 (13)
1 (25)
0.53
Values are given as median (interquartile range), mean ± SD or number of subjects (percentage), unless indicated otherwise
a Mann Whitney U test
b Chi-square test
c Fisher’s exact test
d Independent T test
We further conducted multivariate linear regression analyses with adjustments for age, number of previous CDs, gestational weeks, surgical approach, placental thickness (≥ 50 mm under ultrasound or MRI), and level of PAS penetration (Table 3). We found comparable increases in the intraoperative blood loss, RBC transfusion, surgery duration, and postoperative hospital stay for each level increase of PAS severity from accreta to percreta. When placenta thickness measured more than 50 mm in MRI was added into the model, it was associated with adverse outcomes i.e., more blood loss, RBC transfusion, longer surgery time and hospital stay. The UAL + CST surgical approach significantly reduced the intraoperative blood loss (β=-312 ml, P < .001) and RBC transfusion (β=-1.08 unit, P = .001). Although this technique necessitated more surgery time (β = 16.43 min, P = .01), it conferred no significant changes in postoperative hospital stay.
Table 3
Multivariate linear regression models (N = 210)
 
Model 1 (excluding placenta thickness)
Model 2 (including placenta thickness)
β
95%CI
P Value
β
95%CI
P Value
Intraoperative Blood Loss (ml)
Age
3
-8–14
0.63
6
-6–18
0.33
Previous C-section
143
35–251
0.01
105
-17–226
0.09
Gestation Week
3
-7–14
0.54
0
-12–12
1
UAL + CST a
-312
-449 - -176
< 0.001
-387
-538 - -237
< 0.001
PAS
313
198–429
< 0.001
332
206–458
< 0.001
Placenta thickness
-
-
-
315
99–530
0.01
Intraoperative RBC Transfusion (unit)
Age
0.01
-0.04–0.06
0.76
0.03
-0.03–0.08
0.36
Previous C-section
0.85
0.37–1.34
0.001
0.51
-0.02–1.03
0.06
Gestation Week
-0.03
-0.08–0.02
0.25
-0.05
-0.10–0.00
0.07
UAL + CST a
-1.08
-1.69 - -0.46
0.001
-1.08
-1.73 - -0.44
0.001
PAS
1.32
0.81–1.84
< 0.001
1.35
0.80–1.89
< 0.001
Placenta thickness
-
-
-
1.28
0.35–2.21
0.01
Surgery Duration (min)
Age
0.67
-0.29–1.62
0.17
1.2
0.17–2.24
0.02
Previous C-section
31.43
22.09–40.77
< 0.001
31.2
20.92–41.48
< 0.001
Gestation Week
-0.5
-1.41–0.41
0.28
-0.95
-1.93–0.04
0.06
UAL + CST a
16.43
4.68–28.19
0.01
13.76
1.07–26.45
0.03
PAS
37.57
27.62–47.53
< 0.001
33.89
23.26–44.53
< 0.001
Placenta thickness
-
-
-
48.84
30.64–67.04
< 0.001
Postoperative Hospital Stay
Age
0.05
-0.02–0.12
0.15
0.09
0.02–0.17
0.02
Previous C-section
0.92
0.24–1.61
0.01
0.99
0.22–1.76
0.01
Gestation Week
0
-0.07–0.07
1
-0.03
-0.10–0.05
0.48
UAL + CST a
0.27
-0.59–1.14
0.53
-0.11
-1.06–0.84
0.82
PAS
1.81
1.08–2.53
< 0.001
1.52
0.72–2.31
< 0.001
Placenta thickness
-
-
-
2.58
1.22–3.94
< 0.001
a UAL + CST: uterine artery ligation combined with CST.
Placenta thickness < 50 mm was deemed as 0 and placenta thickness ≥ 50 mm was deemed as 1 in model 2
Next, we conducted a follow-up evaluation of all percreta cases, which is the most severe form of PAS and often has serious and complicated sequelae (Table 4). Out of 19 patients, 5 (26%) patients couldn’t be reached, the average duration of follow-up for the 14 respondents was 20.3 months after delivery, ranging from 10.9 months to 37.8 months. Twelve respondents completed a follow-up gynecological examination, and one case was noted to have abnormal intrauterine adhesions. The majority of these percreta patients (n = 10) resumed a normal menstrual cycle within 12 months from delivery, with an average of 4.8 months (range 1–12 months). There were 3 (21%) patients didn’t resume menstrual cycle, with 1 patient still under breast feeding (censored time: 11 month). Most patients reported normal menstrual fluid volume, with only one case having reduced menstrual fluid volume compared to prior delivery. Additionally, there was one case with dysmenorrhea that existed prior to pregnancy. None of the 14 cases reported abnormal urination or defecation.
Table 4
Follow-up results of severe percreta cases
Subject
Censored Time (month)
Gynecological examination
Gynecological disease
Mense Resumption a
Mense resumption time b
Menses Volume
Abdominal pain
Abnormal urination/
defecation
1
37.8
Yes
No
Yes
2
Normal
No
No
2
37.6
No
/
Yes
1
Normal
No
No
3
36.1
Yes
No
Yes
4
Normal
No
No
4
35.4
Yes
Yes c
No
/
/
No
No
5
33.4
Yes
No
Yes
3
Normal
No
No
6
30.8
Yes
No
No d
/
/
No
No
7
17.5
Yes
No
Yes
3
Normal
No
No
8
16.1
No
/
Yes
6
Normal
No
No
9
13.8
Yes
No
Yes
1
Normal
No
No
10
13.0
Yes
No
No
/
/
No
No
11
10.9
Yes
No
No
/
/
No
No
12
36.0
Yes
No
Yes
12
Decreased
No
No
13
34.2
Yes
No
Yes
8
Normal
Dysmenorrheae
No
14
33.8
Yes
No
Yes
8
Normal
No
No
a Resumption of normal menstrual cycle
b Duration before resumption of normal menstrual cycle since delivery (month)
c Intrauterine adhesions
d Breast-feeding
e Existed prior to delivery
We found that three studied patients, who were identified as PAS before, were pregnant again and delivered in the study center in 2021. Two of them had preterm C-section, the other one had full-term C-section.

Discussion

Since PAS is a life-threatening condition often accompanied with postpartum hemorrhage or hysterectomy, cesarean hysterectomy with the placenta left in situ has been the conventional management approach [26]. However, cesarean hysterectomy is technically challenging, with a high maternal mortality due to massive hemorrhage, and surgical complications such as urinary tract, bowel, or pelvic nerve injuries, in addition to loss of fertility and its accompanying psychological trauma are not uncommon [9]. Moreover, this procedure is not suitable for patients and their families who are keen to preserve fertility.
In contrast to expectant management of leaving the placenta partially or totally in situ, several approaches of conservative management have been developed [27] as have adjunctive techniques for controlling hemorrhage, including pelvic devascularization, embolization, endouterine hemostatic suture, uterine compression suture, use of tissue sealants or mesh, uterine artery balloon placement, embolization or ligation, and postdelivery oxytocin administration [15, 28, 29]. Although randomized trials of conservative management in PAS cases are not available, several case series reported a reduced hysterectomy rate to ~ 20% of PAS patients [30, 31].
In this study, the prominent hallmark of surgical management was the preservation of the uterus without leaving the placenta in situ, which results in significantly less blood loss. In the past, some surgeons in our center performed prophylactic placement of internal iliac artery balloon catheters in conservative management of two PAS cases, but this unfortunately resulted in significant blood loss (data not shown), and therefore this technique was subsequently abandoned. Bilateral uterine artery ligation was later adopted for hemorrhage control combined with a dedicated suture technique. Therefore, the conservative management approach used by the surgical team was manual separation of the placenta combined with ligation of the ascending branch of uterine artery and clover suturing for hemorrhage control (UAL + CST), which has proved to be effective in preventing postpartum hemorrhage [32]. As a result, other surgery teams in the study center gradually adopted this approach.
When China allowed families to have two children instead of limiting to one, there was a 50% increase in annual live births in the study city, peaking in 2017 at 250,857 live births, the highest birth rate growth in China [33]. However, despite the national trend of increased maternal death and surge of PAS cases due to higher maternal age and history of prior CD, there were no maternal deaths related to PAS at this center, suggesting that an effective system of perinatal health management was established. Furthermore, despite a more conservative approach, compared to previous published outcomes of PAS surgical operations, this study suggests that this approach led to comparable or better patient outcomes than total hysterectomy [26, 30, 34, 35]. All women, excluding 3 vaginal deliveries, which were requested by patients themselves, had safe deliveries through elective or emergent cesarean sections. Even considering 18% of CDs were performed emergently, there was a reduction in the average blood loss (611 mL), which is far lower both than immediate hysterectomy of 3000 mL and delayed hysterectomy of 750 mL reported in previous research [36]. Besides, the transfusion rate ( 29%) was lower when compared with 34–78% as previously described [34]. The average operative time (92 min) and length of stay (5.3 days) were comparable to those reported in the literature [34]. Moreover, only a few postoperative complications were reported among 210 PAS cases, including 4 (2%) puerperal infections, 4 (2%) bladder injuries, and 1 (0.5%) follow-up operation. No ureteral injuries, intestinal injuries, or placental remnant were reported. Most importantly, there were no deaths and no total hysterectomies performed. Overall, the present study illustrates a low-risk surgical management strategy as reflected by the described outcomes.
This study demonstrated that the conservative approach of PAS management was safe and could preserve the uterus. In our follow-up with the most severe form of PAS, the majority of percreta patients (n = 10) resumed normal menstrual cycle within 12 months with normal menstrual fluid volume. As PAS is closely related to previous C-section and parity, most of the patients have had two or more than two children, and they usually would not consider fertility issue. The three patients who later delivered again could be the evidence that the studied surgery technique preserved not only the uterus but also the fertility.
Another distinctive finding of this study was the application of MRI in PAS management in a large proportion of cases (~ 44%). After excluding cases with emergency surgeries, which seldom had adequate time for MRI, the rate of MRI in PAS increased to 54%. It is well-known that MRI offers better visualization of maternal pelvic organs, particularly when abnormal invasion (increta and percreta) is suspected, and offers additional detail regarding the utero-placental relationship and the surrounding periuterine environment [14]. There are still controversies about the accuracy of MRI in PAS diagnosis when used as an adjunct to ultrasound [37, 38]. However, MRI in the study center was mainly used for surgical management of PAS, as MRI could provide greater spatial resolution of the entire placenta and presenting the relationships between the uterus and adjacent anatomic structures. Preoperative topology of PAS by MRI has been shown to enable better surgical planning, as it may predict the likelihood of bleeding, postoperative complications, and possibility of uterine repair [39].
It should be acknowledged that part of the reason for the high use of MRI in this study were due to the relatively low cost of MRI at the studied hospital, less than 100 US dollars. We did not find significant impact of use of MRI on blood loss, transfusions, operation durations, hospital stays, and complications. However, in our study, placenta thickness ≥ 50 mm was shown to be closely related to more blood loss and RBC transfusion and longer surgery time and hospital stay. As MRI could obtain a panorama view of placenta and find the thickest part, whereas ultrasound-measured thickness might not be the thickest as it depends on where the probe laid, it is of great value for surgical planning. Moreover, MRI images could be stored permanently and easily accessed by obstetricians and referenced for further training and research, while in contrast, complete ultrasound images were not readily available to the obstetric surgeons for operative planning, and surgeons had to separately request several screenshots of ultrasound images.
It should also be noted that total hysterectomy results in detrimental effects in many aspects of pelvic floor function [40]. In a review of 11 observational studies, developing urinary incontinence after hysterectomy was about 40% higher than those who have not undergone this procedure [41]. In addition, a profound impact of hysterectomies on sexual function has been reported [42]. Moreover, adverse psychological outcomes including post-traumatic stress disorder (PTSD) can result from emergency postpartum hysterectomies [4244]. Thus, it stands to reason that a uterus-preserving approach not only suited the cultural needs of the local population, but also avoided adverse impacts on the quality of life frequently associated with hysterectomy.
We understand that our study should have been conducted as a randomized controlled trial study design. However, PAS is a rare life-threatening pregnancy disorder and the Institutional Review Board would not approve randomization when the studied approach is obviously more effective than other approaches. Besides, this study was limited by its retrospective nature, and may not be generalizable to other regions with different cultural norms, and therefore a different cost-benefit ratio with respect to uterus preservation. As no total hysterectomy were performed at this center, we are unable to directly compare patient outcomes and satisfaction between the studied approach and total hysterectomy.

Conclusions

The current conservative, uterus-preserving management for PAS is safe and effective in the treatment of PAS. Compared with other techniques published in the literature, uterine artery ligation combined with B-Lynch suture was more effective in controlling hemorrhage with a low complication rate. Further research is needed for evaluating long-term outcomes, especially in psychological outcomes.

Acknowledgements

We gratefully acknowledge the Postgraduate Medical Education program and BIDMC’s Health Technology Exploration Center (HTEC) in supporting this collaborative research. We gratefully thank Dr. Yanli Zhang, Dr. Changyu Tu, Huafeng Li, Zhiqiang Zhao, Ruihe Liu, Dr. Xiaoyan Chen, and Dr. Aiqin Hu at Linyi Maternal and Child Healthcare Hospital for their help in conducting this research. We gratefully thank Dr. Lin Zhang at the International Peace Maternity & Child Health Hospital of China Welfare Institute (IPMCH), Shanghai, China for insightful discussion in the study design. We gratefully thank Dr. Xi Zhang at the Clinical Research Unit of Xinhua Hospital affiliated to Shanghai Jiao Tong University for reviewing the statistics methods.

Declarations

This study was approved by the Institutional Review Board of Linyi Maternal and Child Healthcare Hospital. All methods were carried out in accordance with relevant institutional guidelines and regulations. Informed consent was obtained from patients who are followed up for postoperative outcomes.
Not applicable.

Competing interests

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Anhänge

Electronic supplementary material

Below is the link to the electronic supplementary material.
Literatur
1.
Zurück zum Zitat Jauniaux E, Ayres-de-Campos D, Langhoff-Roos J, Fox KA, Collins S, Diagnosis FPA, et al. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet. 2019;146(1):20–4.CrossRefPubMed Jauniaux E, Ayres-de-Campos D, Langhoff-Roos J, Fox KA, Collins S, Diagnosis FPA, et al. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet. 2019;146(1):20–4.CrossRefPubMed
2.
Zurück zum Zitat Jauniaux E, Collins S, Burton GJ. Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. Am J Obstet Gynecol. 2018;218(1):75–87.CrossRefPubMed Jauniaux E, Collins S, Burton GJ. Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. Am J Obstet Gynecol. 2018;218(1):75–87.CrossRefPubMed
3.
Zurück zum Zitat Jauniaux E, Ayres-de-Campos D, Diagnosis FPA. Management Expert Consensus P. FIGO consensus guidelines on placenta accreta spectrum disorders: introduction. Int J Gynaecol Obstet. 2018;140(3):261–4.CrossRefPubMed Jauniaux E, Ayres-de-Campos D, Diagnosis FPA. Management Expert Consensus P. FIGO consensus guidelines on placenta accreta spectrum disorders: introduction. Int J Gynaecol Obstet. 2018;140(3):261–4.CrossRefPubMed
4.
Zurück zum Zitat Bowman ZS, Eller AG, Bardsley TR, Greene T, Varner MW, Silver RM. Risk factors for placenta accreta: a large prospective cohort. Am J Perinatol. 2014;31(9):799–804.PubMed Bowman ZS, Eller AG, Bardsley TR, Greene T, Varner MW, Silver RM. Risk factors for placenta accreta: a large prospective cohort. Am J Perinatol. 2014;31(9):799–804.PubMed
5.
Zurück zum Zitat Eshkoli T, Weintraub AY, Sergienko R, Sheiner E. Placenta accreta: risk factors, perinatal outcomes, and consequences for subsequent births. Am J Obstet Gynecol. 2013;208(3):219e1–7.CrossRef Eshkoli T, Weintraub AY, Sergienko R, Sheiner E. Placenta accreta: risk factors, perinatal outcomes, and consequences for subsequent births. Am J Obstet Gynecol. 2013;208(3):219e1–7.CrossRef
6.
Zurück zum Zitat Fitzpatrick KE, Sellers S, Spark P, Kurinczuk JJ, Brocklehurst P, Knight M. Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study. PLoS ONE. 2012;7(12):e52893.CrossRefPubMedPubMedCentral Fitzpatrick KE, Sellers S, Spark P, Kurinczuk JJ, Brocklehurst P, Knight M. Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study. PLoS ONE. 2012;7(12):e52893.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Salmanian B, Fox KA, Arian SE, Erfani H, Clark SL, Aagaard KM et al. In vitro fertilization as an independent risk factor for placenta accreta spectrum. Am J Obstet Gynecol. 2020. Salmanian B, Fox KA, Arian SE, Erfani H, Clark SL, Aagaard KM et al. In vitro fertilization as an independent risk factor for placenta accreta spectrum. Am J Obstet Gynecol. 2020.
8.
Zurück zum Zitat Publications Committee SfM-FM, Belfort MA. Placenta accreta. Am J Obstet Gynecol. 2010;203(5):430–9.CrossRef Publications Committee SfM-FM, Belfort MA. Placenta accreta. Am J Obstet Gynecol. 2010;203(5):430–9.CrossRef
9.
Zurück zum Zitat Belfort MA, Shamshirsaz AA, Fox KA. The diagnosis and management of morbidly adherent placenta. Semin Perinatol. 2018;42(1):49–58.CrossRefPubMed Belfort MA, Shamshirsaz AA, Fox KA. The diagnosis and management of morbidly adherent placenta. Semin Perinatol. 2018;42(1):49–58.CrossRefPubMed
10.
Zurück zum Zitat Walker MG, Allen L, Windrim RC, Kachura J, Pollard L, Pantazi S, et al. Multidisciplinary management of invasive placenta previa. J Obstet Gynaecol Can. 2013;35(5):417–25.CrossRefPubMed Walker MG, Allen L, Windrim RC, Kachura J, Pollard L, Pantazi S, et al. Multidisciplinary management of invasive placenta previa. J Obstet Gynaecol Can. 2013;35(5):417–25.CrossRefPubMed
11.
Zurück zum Zitat Shamshirsaz AA, Fox KA, Erfani H, Clark SL, Shamshirsaz AA, Nassr AA, et al. Outcomes of planned compared with urgent deliveries using a Multidisciplinary Team Approach for Morbidly Adherent Placenta. Obstet Gynecol. 2018;131(2):234–41.CrossRefPubMed Shamshirsaz AA, Fox KA, Erfani H, Clark SL, Shamshirsaz AA, Nassr AA, et al. Outcomes of planned compared with urgent deliveries using a Multidisciplinary Team Approach for Morbidly Adherent Placenta. Obstet Gynecol. 2018;131(2):234–41.CrossRefPubMed
12.
Zurück zum Zitat Shainker SA, Silver RM, Modest AM, Hacker MR, Hecht JL, Salahuddin S, et al. Placenta accreta spectrum: biomarker discovery using plasma proteomics. Am J Obstet Gynecol. 2020;223(3):433. e1- e14.CrossRef Shainker SA, Silver RM, Modest AM, Hacker MR, Hecht JL, Salahuddin S, et al. Placenta accreta spectrum: biomarker discovery using plasma proteomics. Am J Obstet Gynecol. 2020;223(3):433. e1- e14.CrossRef
13.
Zurück zum Zitat Jauniaux E, Bhide A. Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: a systematic review and meta-analysis. Am J Obstet Gynecol. 2017;217(1):27–36.CrossRefPubMed Jauniaux E, Bhide A. Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: a systematic review and meta-analysis. Am J Obstet Gynecol. 2017;217(1):27–36.CrossRefPubMed
14.
Zurück zum Zitat Brown BP, Meyers ML. Placental magnetic resonance imaging part II: placenta accreta spectrum. Pediatr Radiol. 2020;50(2):275–84.CrossRefPubMed Brown BP, Meyers ML. Placental magnetic resonance imaging part II: placenta accreta spectrum. Pediatr Radiol. 2020;50(2):275–84.CrossRefPubMed
15.
Zurück zum Zitat Sentilhes L, Kayem G, Chandraharan E, Palacios-Jaraquemada J, Jauniaux E, Diagnosis FPA, et al. FIGO consensus guidelines on placenta accreta spectrum disorders: conservative management. Int J Gynaecol Obstet. 2018;140(3):291–8.CrossRefPubMed Sentilhes L, Kayem G, Chandraharan E, Palacios-Jaraquemada J, Jauniaux E, Diagnosis FPA, et al. FIGO consensus guidelines on placenta accreta spectrum disorders: conservative management. Int J Gynaecol Obstet. 2018;140(3):291–8.CrossRefPubMed
16.
Zurück zum Zitat Kocaay AF, Oztuna D, Su FA, Elhan AH, Kuzu MA. Effects of Hysterectomy on Pelvic Floor Disorders: a longitudinal study. Dis Colon Rectum. 2017;60(3):303–10.CrossRefPubMed Kocaay AF, Oztuna D, Su FA, Elhan AH, Kuzu MA. Effects of Hysterectomy on Pelvic Floor Disorders: a longitudinal study. Dis Colon Rectum. 2017;60(3):303–10.CrossRefPubMed
17.
Zurück zum Zitat Forsgren C, Zetterstrom J, Lopez A, Nordenstam J, Anzen B, Altman D. Effects of hysterectomy on bowel function: a three-year, prospective cohort study. Dis Colon Rectum. 2007;50(8):1139–45.CrossRefPubMed Forsgren C, Zetterstrom J, Lopez A, Nordenstam J, Anzen B, Altman D. Effects of hysterectomy on bowel function: a three-year, prospective cohort study. Dis Colon Rectum. 2007;50(8):1139–45.CrossRefPubMed
18.
Zurück zum Zitat Wilson LF, Pandeya N, Byles J, Mishra GD. Hysterectomy and perceived physical function in middle-aged australian women: a 20-year population-based prospective cohort study. Qual Life Res. 2018;27(6):1501–11.CrossRefPubMed Wilson LF, Pandeya N, Byles J, Mishra GD. Hysterectomy and perceived physical function in middle-aged australian women: a 20-year population-based prospective cohort study. Qual Life Res. 2018;27(6):1501–11.CrossRefPubMed
19.
Zurück zum Zitat Fu J, Qu Y, Ji F, Li H, Chen F. A retrospective cohort survey of problems related to second childbirths during the 2-child policy period in Jiangbei District of Ningbo City in China. Med (Baltim). 2018;97(18):e0604.CrossRef Fu J, Qu Y, Ji F, Li H, Chen F. A retrospective cohort survey of problems related to second childbirths during the 2-child policy period in Jiangbei District of Ningbo City in China. Med (Baltim). 2018;97(18):e0604.CrossRef
20.
Zurück zum Zitat Kulakov VI, Karimov ZD. [A method of single-row repair of the lower segment of the uterus during cesarean section]. Akush Ginekol (Mosk). 1994(1):25–8. Kulakov VI, Karimov ZD. [A method of single-row repair of the lower segment of the uterus during cesarean section]. Akush Ginekol (Mosk). 1994(1):25–8.
21.
Zurück zum Zitat Songthamwat S, Songthamwat M. Uterine flexion suture: modified B-Lynch uterine compression suture for the treatment of uterine atony during cesarean section. Int J Womens Health. 2018;10:487–92.CrossRefPubMedPubMedCentral Songthamwat S, Songthamwat M. Uterine flexion suture: modified B-Lynch uterine compression suture for the treatment of uterine atony during cesarean section. Int J Womens Health. 2018;10:487–92.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Allam MS, B-Lynch C. The B-Lynch and other uterine compression suture techniques. Int J Gynecol Obstet. 2005;89(3):236–41.CrossRef Allam MS, B-Lynch C. The B-Lynch and other uterine compression suture techniques. Int J Gynecol Obstet. 2005;89(3):236–41.CrossRef
23.
Zurück zum Zitat JP.Xiao, B.Zhang. Combination of B-Lynch and modified Cho sutures for postpartum hemorrhage caused by low-lying placenta and placenta accreta. Clin Exp Obst & Gyn. 2011;X X X VII(3):274. JP.Xiao, B.Zhang. Combination of B-Lynch and modified Cho sutures for postpartum hemorrhage caused by low-lying placenta and placenta accreta. Clin Exp Obst & Gyn. 2011;X X X VII(3):274.
24.
Zurück zum Zitat Jauniaux E, Bhide A, Kennedy A, Woodward P, Hubinont C, Collins S, et al. FIGO consensus guidelines on placenta accreta spectrum disorders: prenatal diagnosis and screening. Int J Gynaecol Obstet. 2018;140(3):274–80.CrossRefPubMed Jauniaux E, Bhide A, Kennedy A, Woodward P, Hubinont C, Collins S, et al. FIGO consensus guidelines on placenta accreta spectrum disorders: prenatal diagnosis and screening. Int J Gynaecol Obstet. 2018;140(3):274–80.CrossRefPubMed
25.
Zurück zum Zitat Delli Pizzi A, Tavoletta A, Narciso R, Mastrodicasa D, Trebeschi S, Celentano C, et al. Prenatal planning of placenta previa: diagnostic accuracy of a novel MRI-based prediction model for placenta accreta spectrum (PAS) and clinical outcome. Abdom Radiol (NY). 2019;44(5):1873–82.CrossRefPubMed Delli Pizzi A, Tavoletta A, Narciso R, Mastrodicasa D, Trebeschi S, Celentano C, et al. Prenatal planning of placenta previa: diagnostic accuracy of a novel MRI-based prediction model for placenta accreta spectrum (PAS) and clinical outcome. Abdom Radiol (NY). 2019;44(5):1873–82.CrossRefPubMed
26.
Zurück zum Zitat Eller AG, Porter TF, Soisson P, Silver RM. Optimal management strategies for placenta accreta. BJOG. 2009;116(5):648–54.CrossRefPubMed Eller AG, Porter TF, Soisson P, Silver RM. Optimal management strategies for placenta accreta. BJOG. 2009;116(5):648–54.CrossRefPubMed
27.
Zurück zum Zitat American College of Obstetricians and Gynecologists and the Society for Maternal– Fetal Medicine with the assistance of Alison G, Cahill M, Richard Beigi MSCI, MSc MD, Phillips Heine R, Robert MD, Silver M, MD; and, Wax JR. MD. Obstetric Care Consensus No. 7- Placenta Accreta Spectrum. The American College of Obstetricians and Gynecologists. 2018;132(6):e259-e75. American College of Obstetricians and Gynecologists and the Society for Maternal– Fetal Medicine with the assistance of Alison G, Cahill M, Richard Beigi MSCI, MSc MD, Phillips Heine R, Robert MD, Silver M, MD; and, Wax JR. MD. Obstetric Care Consensus No. 7- Placenta Accreta Spectrum. The American College of Obstetricians and Gynecologists. 2018;132(6):e259-e75.
28.
Zurück zum Zitat Agostini A, Vejux N, Bretelle F, Collette E, De Lapparent T, Cravello L, et al. Value of laparoscopic assistance for vaginal hysterectomy with prophylactic bilateral oophorectomy. Am J Obstet Gynecol. 2006;194(2):351–4.CrossRefPubMed Agostini A, Vejux N, Bretelle F, Collette E, De Lapparent T, Cravello L, et al. Value of laparoscopic assistance for vaginal hysterectomy with prophylactic bilateral oophorectomy. Am J Obstet Gynecol. 2006;194(2):351–4.CrossRefPubMed
29.
Zurück zum Zitat Su HW, Yi YC, Tseng JJ, Chen WC, Chen YF, Kung HF, et al. Maternal outcome after conservative management of abnormally invasive placenta. Taiwan J Obstet Gynecol. 2017;56(3):353–7.CrossRefPubMed Su HW, Yi YC, Tseng JJ, Chen WC, Chen YF, Kung HF, et al. Maternal outcome after conservative management of abnormally invasive placenta. Taiwan J Obstet Gynecol. 2017;56(3):353–7.CrossRefPubMed
30.
Zurück zum Zitat Dai M, Jin G, Lin J, Zhang Y, Chen Y, Zhou Q, et al. Control of postpartum hemorrhage in women with placenta accreta spectrum using prophylactic balloon occlusion combined with pituitrin intra-arterial infusion. Eur Radiol. 2020;30(8):4524–33.CrossRefPubMed Dai M, Jin G, Lin J, Zhang Y, Chen Y, Zhou Q, et al. Control of postpartum hemorrhage in women with placenta accreta spectrum using prophylactic balloon occlusion combined with pituitrin intra-arterial infusion. Eur Radiol. 2020;30(8):4524–33.CrossRefPubMed
31.
Zurück zum Zitat Pala S, Atilgan R, Baspinar M, Kavak EC, Yavuzkir S, Akyol A, et al. Comparison of results of Bakri balloon tamponade and caesarean hysterectomy in management of placenta accreta and increta: a retrospective study. J Obstet Gynaecol. 2018;38(2):194–9.CrossRefPubMed Pala S, Atilgan R, Baspinar M, Kavak EC, Yavuzkir S, Akyol A, et al. Comparison of results of Bakri balloon tamponade and caesarean hysterectomy in management of placenta accreta and increta: a retrospective study. J Obstet Gynaecol. 2018;38(2):194–9.CrossRefPubMed
32.
Zurück zum Zitat Joshi VM, Otiv SR, Majumder R, Nikam YA, Shrivastava M. Internal iliac artery ligation for arresting postpartum haemorrhage. BJOG. 2007;114(3):356–61.CrossRefPubMed Joshi VM, Otiv SR, Majumder R, Nikam YA, Shrivastava M. Internal iliac artery ligation for arresting postpartum haemorrhage. BJOG. 2007;114(3):356–61.CrossRefPubMed
33.
Zurück zum Zitat Zeng Y, Hesketh T. The effects of China’s universal two-child policy. The Lancet. 2016;388(10054):1930–8.CrossRef Zeng Y, Hesketh T. The effects of China’s universal two-child policy. The Lancet. 2016;388(10054):1930–8.CrossRef
34.
Zurück zum Zitat Mitric C, Desilets J, Balayla J, Ziegler C. Surgical Management of the Placenta Accreta Spectrum: an institutional experience. J Obstet Gynaecol Can. 2019;41(11):1551–7.CrossRefPubMed Mitric C, Desilets J, Balayla J, Ziegler C. Surgical Management of the Placenta Accreta Spectrum: an institutional experience. J Obstet Gynaecol Can. 2019;41(11):1551–7.CrossRefPubMed
35.
Zurück zum Zitat Grace Tan SE, Jobling TW, Wallace EM, McNeilage LJ, Manolitsas T, Hodges RJ. Surgical management of placenta accreta: a 10-year experience. Acta Obstet Gynecol Scand. 2013;92(4):445–50.CrossRefPubMed Grace Tan SE, Jobling TW, Wallace EM, McNeilage LJ, Manolitsas T, Hodges RJ. Surgical management of placenta accreta: a 10-year experience. Acta Obstet Gynecol Scand. 2013;92(4):445–50.CrossRefPubMed
36.
Zurück zum Zitat Zuckerwise LC, Craig AM, Newton JM, Zhao S, Bennett KA, Crispens MA. Outcomes following a clinical algorithm allowing for delayed hysterectomy in the management of severe placenta accreta spectrum. Am J Obstet Gynecol. 2020;222(2):179e1-.e9.CrossRef Zuckerwise LC, Craig AM, Newton JM, Zhao S, Bennett KA, Crispens MA. Outcomes following a clinical algorithm allowing for delayed hysterectomy in the management of severe placenta accreta spectrum. Am J Obstet Gynecol. 2020;222(2):179e1-.e9.CrossRef
37.
Zurück zum Zitat Einerson BD, Rodriguez CE, Kennedy AM, Woodward PJ, Donnelly MA, Silver RM. Magnetic resonance imaging is often misleading when used as an adjunct to ultrasound in the management of placenta accreta spectrum disorders. Am J Obstet Gynecol. 2018;218(6):618. e1- e7.CrossRef Einerson BD, Rodriguez CE, Kennedy AM, Woodward PJ, Donnelly MA, Silver RM. Magnetic resonance imaging is often misleading when used as an adjunct to ultrasound in the management of placenta accreta spectrum disorders. Am J Obstet Gynecol. 2018;218(6):618. e1- e7.CrossRef
38.
Zurück zum Zitat Clark HR, Ng TW, Khan A, Happe S, Dashe J, Xi Y, et al. Placenta Accreta Spectrum: correlation of MRI parameters with Pathologic and Surgical Outcomes of High-Risk Pregnancies. AJR Am J Roentgenol. 2020;214(6):1417–23.CrossRefPubMed Clark HR, Ng TW, Khan A, Happe S, Dashe J, Xi Y, et al. Placenta Accreta Spectrum: correlation of MRI parameters with Pathologic and Surgical Outcomes of High-Risk Pregnancies. AJR Am J Roentgenol. 2020;214(6):1417–23.CrossRefPubMed
39.
Zurück zum Zitat Palacios-Jaraquemada JM, Fiorillo A, Hamer J, Martinez M, Bruno C. Placenta accreta spectrum: a hysterectomy can be prevented in almost 80% of cases using a resective-reconstructive technique. J Matern Fetal Neonatal Med. 2020:1–8. Palacios-Jaraquemada JM, Fiorillo A, Hamer J, Martinez M, Bruno C. Placenta accreta spectrum: a hysterectomy can be prevented in almost 80% of cases using a resective-reconstructive technique. J Matern Fetal Neonatal Med. 2020:1–8.
40.
Zurück zum Zitat Selcuk S, Cam C, Asoglu MR, Kucukbas M, Arinkan A, Cikman MS, et al. Effect of simple and radical hysterectomy on quality of life - analysis of all aspects of pelvic floor dysfunction. Eur J Obstet Gynecol Reprod Biol. 2016;198:84–8.CrossRefPubMed Selcuk S, Cam C, Asoglu MR, Kucukbas M, Arinkan A, Cikman MS, et al. Effect of simple and radical hysterectomy on quality of life - analysis of all aspects of pelvic floor dysfunction. Eur J Obstet Gynecol Reprod Biol. 2016;198:84–8.CrossRefPubMed
41.
Zurück zum Zitat Brown JS, Sawaya G, Thom DH, Grady D. Hysterectomy and urinary incontinence: a systematic review. The Lancet. 2000;356(9229):535–9.CrossRef Brown JS, Sawaya G, Thom DH, Grady D. Hysterectomy and urinary incontinence: a systematic review. The Lancet. 2000;356(9229):535–9.CrossRef
42.
Zurück zum Zitat Jensen PT, Groenvold M, Klee MC, Thranov I, Petersen MA, Machin D. Early-stage cervical carcinoma, radical hysterectomy, and sexual function. A longitudinal study. Cancer. 2004;100(1):97–106.CrossRefPubMed Jensen PT, Groenvold M, Klee MC, Thranov I, Petersen MA, Machin D. Early-stage cervical carcinoma, radical hysterectomy, and sexual function. A longitudinal study. Cancer. 2004;100(1):97–106.CrossRefPubMed
43.
Zurück zum Zitat de la Cruz CZ, Coulter M, O’Rourke K, Mbah AK, Salihu HM. Post-traumatic stress disorder following emergency peripartum hysterectomy. Arch Gynecol Obstet. 2016;294(4):681–8.CrossRefPubMed de la Cruz CZ, Coulter M, O’Rourke K, Mbah AK, Salihu HM. Post-traumatic stress disorder following emergency peripartum hysterectomy. Arch Gynecol Obstet. 2016;294(4):681–8.CrossRefPubMed
44.
Zurück zum Zitat Zaat TR, van Steijn ME, de Haan-Jebbink JM, Olff M, Stramrood CAI, van Pampus MG. Posttraumatic stress disorder related to postpartum haemorrhage: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2018;225:214–20.CrossRefPubMed Zaat TR, van Steijn ME, de Haan-Jebbink JM, Olff M, Stramrood CAI, van Pampus MG. Posttraumatic stress disorder related to postpartum haemorrhage: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2018;225:214–20.CrossRefPubMed
Metadaten
Titel
Uterus-preserving surgical management of placenta accreta spectrum disorder: a large retrospective study
verfasst von
Wenxia Pan
Juan Chen
Yinrui Zou
Kun Yang
Qingfeng Liu
Meiying Sun
Dan Li
Ping Zhang
Shixia Yue
Yuqiang Huang
Zhaoxi Wang
Publikationsdatum
01.12.2023
Verlag
BioMed Central
Erschienen in
BMC Pregnancy and Childbirth / Ausgabe 1/2023
Elektronische ISSN: 1471-2393
DOI
https://doi.org/10.1186/s12884-023-05923-9

Weitere Artikel der Ausgabe 1/2023

BMC Pregnancy and Childbirth 1/2023 Zur Ausgabe

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

13.05.2024 Gestationsdiabetes Nachrichten

Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.